Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


Articles published in Clin Nucl Med

Retrieve available abstracts of 64 articles:
HTML format
Text format



Single Articles


    April 2018
  1. ZHAO Z, Zhou K, Liu B
    Added Value of SPECT/CT in the Evaluation of Sacral Fracture in Patients With Lung Cancer.
    Clin Nucl Med. 2018 Apr 13. doi: 10.1097/RLU.0000000000002082.
    PubMed     Text format     Abstract available


    March 2018
  2. WILSON B, Becker A, Estes T, Keshavamurthy J, et al
    Adrenal Hemangioma Definite Diagnosis on CT, MRI, and FDG PET in a Patient With Primary Lung Cancer.
    Clin Nucl Med. 2018 Mar 20. doi: 10.1097/RLU.0000000000002069.
    PubMed     Text format     Abstract available


  3. CHENG J, Ou X, Ye Y
    Prominent Pulmonary Metastases Without Concurrent Intra-abdominal Metastasis in a Case of Ovarian Carcinoma.
    Clin Nucl Med. 2018 Mar 7. doi: 10.1097/RLU.0000000000002045.
    PubMed     Text format     Abstract available


    February 2018
  4. JOCHUMSEN MR, Gormsen LC, Nielsen GL
    68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.
    Clin Nucl Med. 2018;43:117-119.
    PubMed     Text format     Abstract available


    December 2017
  5. ESHGHI N, Lundeen TF, Kuo PH
    Dynamic Adaptation of Tumor Immune Response With Nivolumab Demonstrated by 18F-FDG PET/CT.
    Clin Nucl Med. 2017 Dec 19. doi: 10.1097/RLU.0000000000001934.
    PubMed     Text format     Abstract available


  6. FRANKL J, Eshghi N, Lundeen TF, Kuo PH, et al
    Artifactual Hepatic Metastasis on FDG PET/CT Secondary to Cryoablation for Adrenal Metastasis.
    Clin Nucl Med. 2017 Dec 11. doi: 10.1097/RLU.0000000000001917.
    PubMed     Text format     Abstract available


  7. DERLIN T, Hartung D, Hueper K
    68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Extra-adrenal Paraganglioma in a Case of Complete Carney Triad.
    Clin Nucl Med. 2017;42:e527-e528.
    PubMed     Text format     Abstract available


    November 2017
  8. CALANDRIELLO L, Larici AR, Leccisotti L, Del Ciello A, et al
    Multifunctional Assessment of Non-Small Cell Lung Cancer: Perfusion-Metabolic Correlation.
    Clin Nucl Med. 2017 Nov 17. doi: 10.1097/RLU.0000000000001888.
    PubMed     Text format     Abstract available


  9. PAN Y, Zhang Y
    Simultaneous Brain and Lung Histiocytic Sarcoma Revealed on 18F-FDG PET/CT.
    Clin Nucl Med. 2017 Nov 17. doi: 10.1097/RLU.0000000000001908.
    PubMed     Text format     Abstract available


  10. SHARMA A, Mohan A, Bhalla AS, Sharma MC, et al
    Role of Various Metabolic Parameters Derived From Baseline 18F-FDG PET/CT as Prognostic Markers in Non-Small Cell Lung Cancer Patients Undergoing Platinum-Based Chemotherapy.
    Clin Nucl Med. 2017 Nov 3. doi: 10.1097/RLU.0000000000001886.
    PubMed     Text format     Abstract available


    October 2017
  11. MAGARIK MA, Walker RC, Gilbert J, Manning HC, et al
    Intracardiac Metastases Detected by 18F-FSPG PET/CT.
    Clin Nucl Med. 2017 Oct 26. doi: 10.1097/RLU.0000000000001883.
    PubMed     Text format     Abstract available


    August 2017
  12. SHARMA P, Dwary AD, Khan EM
    Serendipitous Discovery of Isolated Gastric Metastases From Adenocarcinoma of the Lung on Staging 18F-FDG PET-CT.
    Clin Nucl Med. 2017 Aug 12. doi: 10.1097/RLU.0000000000001784.
    PubMed     Text format     Abstract available


  13. HAROLDS JA
    Quality and Safety in Health Care, Part XXV: General Thoracic Surgery.
    Clin Nucl Med. 2017;42:606-607.
    PubMed     Text format     Abstract available


    July 2017
  14. WANG W, Yuan L, Kan Y, Yang J, et al
    Oligometastatic Stomach Carcinoma From Lung Squamous Cell Carcinoma Detected by 18F-FDG PET/CT.
    Clin Nucl Med. 2017 Jul 17. doi: 10.1097/RLU.0000000000001761.
    PubMed     Text format     Abstract available


  15. GAO R, Gao S, Feng J, Wang Y, et al
    Diffuse Thyroid Metastasis From Lung Cancer Mimicking Thyroiditis on 99mTc-Pertechnetate Scintigraphy.
    Clin Nucl Med. 2017 Jul 6. doi: 10.1097/RLU.0000000000001755.
    PubMed     Text format     Abstract available


    June 2017
  16. LI ZG
    Solitary Choroidal Metastasis From Lung Adenocarcinoma on FDG PET/CT.
    Clin Nucl Med. 2017 Jun 24. doi: 10.1097/RLU.0000000000001738.
    PubMed     Text format     Abstract available


  17. KARA PO, Koc ZP, Citak EC, Nayci A, et al
    Rare Endobronchial Inflammatory Myofibroblastic Tumor in Pediatric Patient Detected on PET/CT Imaging.
    Clin Nucl Med. 2017 Jun 20. doi: 10.1097/RLU.0000000000001737.
    PubMed     Text format     Abstract available


  18. VAZ SC, Oliveira C, Castanheira JC, Silva AF, et al
    18F-FDG Uptake in Ischemic Colitis During Follow-up of a Patient With Lung Cancer.
    Clin Nucl Med. 2017 Jun 19. doi: 10.1097/RLU.0000000000001723.
    PubMed     Text format     Abstract available


  19. SOMMERFELDT J, Miao TL, Zuckier LS, Gupta A, et al
    High Prevalence of Pneumothorax on PET-CT Studies Performed in Lung Cancer Patients Following Post-Transthoracic Needle Biopsy Mandates Careful Scrutiny.
    Clin Nucl Med. 2017 Jun 5. doi: 10.1097/RLU.0000000000001716.
    PubMed     Text format     Abstract available


  20. WANG Y, Shao F, Zhang L, Luo X, et al
    Increased 18F-FDG Uptake in Multiple Muscles in a Patient With Violent Cough.
    Clin Nucl Med. 2017;42:451-453.
    PubMed     Text format     Abstract available


  21. PARGHANE RV, Talole S, Prabhash K, Basu S, et al
    Clinical Response Profile of Metastatic/Advanced Pulmonary Neuroendocrine Tumors to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.
    Clin Nucl Med. 2017;42:428-435.
    PubMed     Text format     Abstract available


    May 2017
  22. MAPELLI P, Incerti E, Fallanca F, Bettinardi V, et al
    Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT.
    Clin Nucl Med. 2017 May 19. doi: 10.1097/RLU.0000000000001704.
    PubMed     Text format     Abstract available


  23. SAMPAIO VIEIRA T, Borges Faria D, Azevedo Silva F, Pimentel F, et al
    The Impact of a Bayesian Penalized Likelihood Reconstruction Algorithm on the Evaluation of Indeterminate Pulmonary Nodules by Dual-Time Point 18F-FDG PET/CT.
    Clin Nucl Med. 2017 May 19. doi: 10.1097/RLU.0000000000001713.
    PubMed     Text format     Abstract available


  24. GROE HOKAMP N, Kobe C, Linzenich E, Maintz D, et al
    Solitary PSMA-Positive Pulmonary Metastasis in Biochemical Relapse of Prostate Cancer.
    Clin Nucl Med. 2017;42:406-407.
    PubMed     Text format     Abstract available


    April 2017
  25. SAVELLI G, Bna C, Zambelli C, Illuminati S, et al
    An 111In-Pentetreotide Positive Sclerosing Pneumocytoma.
    Clin Nucl Med. 2017;42:282-284.
    PubMed     Text format     Abstract available


    March 2017
  26. JANSSEN I, Wolf KI, Chui CH, Millo CM, et al
    Relevant Discordance Between 68Ga-DOTATATE and 68Ga-DOTANOC in SDHB-Related Metastatic Paraganglioma: Is Affinity to Somatostatin Receptor 2 the Key?
    Clin Nucl Med. 2017;42:211-213.
    PubMed     Text format     Abstract available


    February 2017
  27. FU Z, Liu M, Zhang J, Li Z, et al
    Nasal-Tip Metastasis on 18 F-FDG PET/CT Scan in a Patient With Squamous Lung Carcinoma.
    Clin Nucl Med. 2017 Feb 24. doi: 10.1097/RLU.0000000000001597.
    PubMed     Text format     Abstract available


  28. XIE P, Huang J
    Solitary Thumb Acrometastasis Identified on Bone Scintigraphy.
    Clin Nucl Med. 2017 Feb 24. doi: 10.1097/RLU.0000000000001621.
    PubMed     Text format     Abstract available


  29. BAI X, Zhuang H
    Prominent Pulmonary Metastases Without Concurrent Osseous Involvement in Patients With High-Risk Neuroblastoma.
    Clin Nucl Med. 2017 Feb 13. doi: 10.1097/RLU.0000000000001579.
    PubMed     Text format     Abstract available


    January 2017
  30. ABUBAKAR S, Amoako YA, Kotze T, Tag N, et al
    Source of Ectopic ACTH Secretion Easily Identified by 68Ga DOTANOC PET/CT.
    Clin Nucl Med. 2017 Jan 16. doi: 10.1097/RLU.0000000000001541.
    PubMed     Text format     Abstract available


    December 2016
  31. VADRUCCI M, Gilardi L, Crivelli F, Baroli A, et al
    18F-FDG PET/CT in Metastatic Pilomatrix Carcinoma.
    Clin Nucl Med. 2016;41:e525-e526.
    PubMed     Text format     Abstract available


  32. PANAGIOTIDIS E, Seshadri N, Fernando R, Healey P, et al
    68Ga-DOTANOC Focal Pulmonary Activity With No Corresponding CT Abnormality.
    Clin Nucl Med. 2016;41:948-950.
    PubMed     Text format     Abstract available


  33. LI W, Li W, Zhang R
    Metastasis to the Medial Cuneiform Bone from Squamous Cell Carcinoma of the Lung Revealed by Bone Scintigraphy.
    Clin Nucl Med. 2016;41:946-947.
    PubMed     Text format     Abstract available


    October 2016
  34. HSU J, Jia L, Pucar D, Williams H, et al
    Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia and Granulomatous Inflammation Mimicking High-Grade Malignancy on FDG-PET/CT.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  35. QUTBI M, Shafeie B, Amoui M, Tabeie F, et al
    Evaluation of Prognostic Factors Associated With Differentiated Thyroid Carcinoma With Pulmonary Metastasis.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  36. KHOO AC, Hamzah F, Ong CK
    Incidental Sclerosing Pneumocytoma Detected on Bone Scintigraphy.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  37. SHETTY D, Loh H, Bui C, Mansberg R, et al
    Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma.
    Clin Nucl Med. 2016;41:776-8.
    PubMed     Text format     Abstract available


    September 2016
  38. MAYERHOEFER ME, Karanikas G, Kletter K, Kiesewetter B, et al
    Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  39. DEJUST S, Morland D, Fabre G, Prevost A, et al
    18F-FDG PET/CT Evaluation of Ceritinib Therapy in Metastatic ALK-Positive Non-small Cell Lung Cancer.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  40. CRESPO-JARA A, Gonzalez Manzano R, Lopera Sierra M, Redal Pena MC, et al
    A Patient With Metastatic Sarcoma was Successfully Treated With Radiolabeled Somatostatin Analogs.
    Clin Nucl Med. 2016;41:705-7.
    PubMed     Text format     Abstract available


    August 2016
  41. CHEN YR, Kuo YC, Hsu CN, Hsieh TC, et al
    False Suggestion of Malignant Transformation of Benign Bone Tumor by 18F-FDG PET/CT: A Potential Pitfall.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    July 2016
  42. HUNG TJ, Macdonald W, Muir T, Celliers L, et al
    68Ga DOTATATE PET/CT of Non-FDG-Avid Pulmonary Metastatic Hemangiopericytoma.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  43. ZHENG N, Bai X, Niu R, Wang X, et al
    Primary Pulmonary Mucinous Adenocarcinoma Was Better Visualized on Delayed FDG PET/CT Imaging.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    June 2016
  44. DO VALE RH, Queiroz MA, Coutinho AM, Buchpiguel CA, et al
    18F-FDG PET/CT Osteometabolic Activity in Metastatic Parathyroid Carcinoma.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  45. LUTJE S, Sauerwein W, Lauenstein T, Bockisch A, et al
    In Vivo Visualization of Prostate-Specific Membrane Antigen in Adenoid Cystic Carcinoma of the Salivary Gland.
    Clin Nucl Med. 2016;41:476-7.
    PubMed     Text format     Abstract available


    May 2016
  46. LI B, Zhang Y, Hou J, Yu H, et al
    Primary Liver Carcinosarcoma and 18F-FDG PET/CT.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  47. OLDAN JD, Chin BB
    FDG PET/CT Imaging of Prostate Carcinosarcoma.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  48. SALGARELLO M, Lunardi G, Inno A, Pasetto S, et al
    18F-NaF PET/CT Imaging of Brain Metastases.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    April 2016
  49. WANG S, Li M, Chen H, Li J, et al
    FDG PET/CT in Hepatoid Adenocarcinoma of the Lung.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  50. CHENG G
    A Case of Lung Squamous Cell Carcinoma With Duodenal Metastasis on FDG PET/CT.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    February 2016
  51. WU F, Wang Z, Xing X, Yu M, et al
    The Value of 18F-FDG PET/CT in Diagnostic Procedure of Intravascular Large B-Cell Lymphoma Presenting Fever of Unknown Origin and Pulmonary Hypertension as an Initial Manifestation.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    January 2016
  52. SHETTY D, Loh H, Bui C, Mansberg R, et al
    Elevated 68Ga Prostate-Specific Membrane Antigen Activity in Metastatic Non-Small Cell Lung Cancer.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  53. UHLEN N, Grundberg O, Jacobsson H, Sundin A, et al
    18F-FDG PET/CT Diagnosis of Bronchopulmonary Carcinoids Versus Pulmonary Hamartomas.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  54. LEE JW, Lee SM, Yun M, Cho A, et al
    Prognostic Value of Volumetric Parameters on Staging and Posttreatment FDG PET/CT in Patients With Stage IV Non-Small Cell Lung Cancer.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


  55. DERLIN T, Jonigk D, Bauersachs J, Bengel FM, et al
    Molecular Imaging of Chemokine Receptor CXCR4 in Non-Small Cell Lung Cancer Using 68Ga-Pentixafor PET/CT: Comparison With 18F-FDG.
    Clin Nucl Med. 2016.
    PubMed     Text format     Abstract available


    November 2015
  56. ERHAMAMCI S, Reyhan M, Canpolat T, Nursal GN, et al
    A Case of a Man With Isolated Breast Metastasis From Lung Adenocarcinoma Incidentally Detected by FDG PET/CT.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


  57. GUO Y, Wang T, Yang M
    Pulmonary Artery Sarcoma Detected on 18F-FDG PET/CT With Unusual Findings.
    Clin Nucl Med. 2015;40:e530-1.
    PubMed     Text format     Abstract available


    October 2015
  58. NOUGARET S, Ragucci M, Bach AM, Carollo G, et al
    Incidental Detection of Femoral Pseudoaneurysm at 18F-FDG PET/CT.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


  59. ZHANG L, Zhang X, Zhang R, Fan W, et al
    18F-FDG PET/CT Metabolic Activity in a Patient With Solitary Extramedullary Plasmacytoma of the Lung.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


    September 2015
  60. JIANG L, Chen S, Li Y, Chen G, et al
    Primary Tracheal and Bronchial Lymphoma Displayed on 18F-FDG PET/CT Imaging.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


    July 2015
  61. TATCI E, Gokcek A, Unsal E, Cimen F, et al
    FDG PET/CT Findings of Recurrent Respiratory Papillomatosis With Malignant Degeneration in the Lung.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


    June 2015
  62. HO TY, Chou PC, Yang CT, Tsang NM, et al
    Total lesion glycolysis determined per RECIST 1.1 criteria predicts survival in EGFR mutation-negative patients with advanced lung adenocarcinoma.
    Clin Nucl Med. 2015;40:e295-9.
    PubMed     Text format     Abstract available


  63. BAI X, Yang H, Zhuang H
    Asymmetric thoracic metaiodobenzylguanidine (MIBG) activity due to prior radiation therapy.
    Clin Nucl Med. 2015;40:e338-40.
    PubMed     Text format     Abstract available


    February 2015
  64. PALARD X, Carai S, Le Roux PY, Salaun PY, et al
    Asymmetric Muscle Activity on 18F-FDG PET/CT.
    Clin Nucl Med. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: